Ross Youngs is a renowned entrepreneur and innovator who has made significant contributions to several industries, including pharmaceuticals, agriculture, and cosmetics. He is the CEO and Founder of Biosortia Pharmaceuticals, a game-changing startup that has developed groundbreaking technology to extract drug-like signaling molecules from previously unobtainable sources. Under his leadership and persistence, Biosortia has received equity funding of over $11 million and non-dilute funding of over $9 million from prestigious organizations such as ARPA-E, DARPA, and the USAFRL. One of the most notable achievements of Biosortia includes publishing a major peer-reviewed paper in 2018 that received the American Chemical Society's 'Editors Choice Award.' With a million-dollar contract with a US Government Agency set to begin in October 2019, Biosortia is poised to revolutionize the pharmaceutical and allied industries with Ross at the helm.

While Ross has a rich history of entrepreneurship, he also has a formidable academic background. He studied Industrial Engineering at Indiana University-Purdue University Indianapolis and Florida Institute of Technology. In addition to his contributions to Biosortia, Ross has also made significant contributions to several other brands, inventions, and companies such as Unikeep.com, EnvyPak.com, Cardnoter.com, Univenture.com, Packzen.com, and ShareServices.com.

Ross's awards and recognitions speak volumes about his leadership, influence, and innovation in various fields. He was named the National Business Person of the Year in 1998 by the SBA, has been recognized by INC. Magazine as a Hall of Fame entrepreneur and a Five Time Inc. 500 CEO, and was awarded Ernst & Young Entrepreneur of Year Ohio. He has over 75 international patents issued, a testament to his innovative prowess.